IBRX · ImmunityBio, Inc.

Summary

ImmunityBio, Inc. filed an 8-K on February 18, 2026, under Items 8.01 and 9.01, attaching Exhibit 99.1, a press release dated February 18, 2026. Item 8.01 disclosures, including the exhibit, are not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.

Key takeaways

• Filing date: 2026-02-18
• Form Type: 8-K
• Items reported: 8.01 and 9.01
• Exhibit 99.1: Press release dated February 18, 2026
• Item 8.01 not deemed filed under Section 18